| Authors: |
Pratz KW; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA., Kaplan J; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL., Levy M; Baylor University Medical Center, Dallas, TX., Bixby D; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Burke PW; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Erba H; Duke University School of Medicine, Durham, NC., Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, OH., Roboz GJ; Weill Cornell Medical College, New York, NY., Papadantonakis N; Winship Cancer Institute of Emory University, Atlanta, GA., Rajkhowa T; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Hernandez D; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Dobler I; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Gregory RC; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Li C; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Wang S; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Stumpo K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Kannan K; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Miao H; Takeda Development Center Americas, Inc. (TDCA), Cambridge, MA., Levis M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. levisma@jhmi.edu. |